Business Wire

Q4-INC.

Share
Q4 Inc. Announces Participation in Upcoming Investor Events

Q4 Inc. (TSX: QFOR), a leading capital markets communications platform, announces its participation in upcoming investor events including fireside chat and investor conferences.

March 29th, 2022: Canaccord Genuity Tech 2022, Themes in a Stock Picker's Market

Darrell Heaps, Chief Executive Officer, will be participating in a virtual Fireside Chat at Canaccord Genuity Tech 2022: Themes in a Stock Picker’s Market event. Darrell will be speaking on the Spending to be a Category Killer - Growth vs. Profitability panel at 9:00 am ET. Those interested in attending please register with Canaccord Genuity, via their Registration Link .

March 28-30th, 2022: Maxim 2022 Virtual Growth Conference

Darrell Heaps, Chief Executive Officer and Ryan Levenberg, Chief Financial Officer will host a virtual presentation and investor meetings on March 29th at the M-Vest Virtual Conference Series: 2022 Virtual Growth Conference. Those interested in attending can register here . The presentation will be available following the event at https://m-vest.com/events/2022-virtual-growth-conference/p/qfor .

April 7th, 2022: Credit Suisse The Investor Landscape Hidden Gems Conference

Q4 Inc. will be participating in the Credit Suisse Hidden Gems conference, April 7th in New York. The event will include in person investor meetings and panel discussions. We look forward to seeing investors in person. Following the event, a copy of the presentation will be on Q4’s Investor website at https://investors.q4inc.com/ .

About Q4 Inc .

Q4 Inc. (TSX: QFOR) is a leading capital markets communications platform that is transforming the way publicly traded companies, investors and investment banks make decisions to efficiently discover, communicate and engage with each other. The Q4 end-to-end technology platform facilitates interactions across the capital markets through its IR website products, virtual events solutions, capital markets CRM, shareholder and market analytics tools. The firm is a trusted partner to more than 2,600 public companies globally including many of the most respected brands in the world. Q4 is based in Toronto, with offices in New York and London. Learn more at q4inc.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Canva Launches Creative Operating System30.10.2025 18:00:00 CET | Press release

Next era of Canva combines a supercharged Visual Suite, world-first design AI, and powerful tools to grow your brand Canva Design Model: World-first AI model that understands complexities and ingredients of design. AI Where You Work: Bring your imagination to life in every part of the design process, plus, a new design assistant. Video 2.0: A reimagined video editor makes professional and engaging content effortless. Canva Grow: Powerful marketing engine to ideate, create, distribute, and refine engaging ads to scale your brand. All-New Affinity: All-in-one app built by pro designers for pro designers, now forever free. Forms: Design interactive forms that can be added to any design for everything from RSVP forms to contact pages. Email Design: Design engaging emails with Canva’s drag-and-drop editor, then export to your platform of choice. Canva Code in Sheets: Seamlessly link interactive widgets with Canva Sheets to bring data to life in real time. Canva, the world’s only all-in-one

Svante Celebrates 18 Years of Carbon Management Innovation with Historic Milestones in 202530.10.2025 17:25:00 CET | Press release

Svante Technologies Inc. (Svante), a global leader in carbon capture and removal solutions, proudly marks its 18th anniversary this month, celebrating nearly two decades of pioneering industrial carbon management technology. This year has been one of the most transformative in Svante’s history, defined by bold innovation, strategic partnerships, and the commissioning of the world’s first commercial manufacturing facility for solid sorbent-based carbon capture and removal filters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030974500/en/ Founded in 2007 with a vision to revolutionize how the world manages carbon dioxide emissions, Svante has grown into a cornerstone of the global carbon management industry. In 2025, that vision took a monumental leap forward with the launch of the Redwood Facility in Burnaby, BC — a 141,000-square-foot Centre of Excellence for Carbon Capture and Removal. This first-of-its-kind manufactu

Ireland Unveils Seven New Halloween Experiences30.10.2025 15:00:00 CET | Press release

More celebrations than ever across the island of Ireland – the true Home of Halloween With seven brand-new Halloween hubs or experiences launching across the island this month, Ireland has truly become the ultimate destination to celebrate Halloween in 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251022209535/en/ Derry Halloween Festival, County Derry~Londonderry Ireland’s Halloween Season Rooted in the ancient Celtic festival of Samhain, Halloween originated in Ireland more than 2,000 years ago and, this year, the island of Ireland is expanding its celebration like never before. With over 340 events planned across the island to celebrate this year, Halloween in Ireland is fast becoming a bucket-list travel experience. Seven new Halloween hubs join existing flagship events across the island of Ireland including the Púca Festival in County Meath and Derry Halloween in Derry-Londonderry which together welcomed over 169

Staloral® Birch Phase III Study Successfully Meets Primary Endpoint, Demonstrating Efficacy in Children and Adolescents30.10.2025 14:56:00 CET | Press release

Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of Staloral® Birch in children and adolescents with birch pollen-induced allergic rhino-conjunctivitis (ARC), with or without asthma, has successfully achieved its primary endpoint. The trial enrolled 553 children aged 5 -17 years with moderate to severe birch pollen-induced ARC, with or without asthma, across 64 sites in 12 European countries and assessed the efficacy and safety of Staloral® birch 300IR daily maintenance dose administered pre-and co-seasonally over two consecutive birch pollen seasons. The YOBI study successfully met its primary endpoint, demonstrating the efficacy of Staloral® Birch in a paediatric population (5-17) with a 41% improvement in the ARC total combined score during the second pollen season compared to placebo. These results were highly statistically significant

Debiopharm Forges AI-powered Alliance With NetTargets to Pioneer Dual-payload ADCs Against Drug-resistant Cancers30.10.2025 14:00:00 CET | Press release

An Alliance to Combat Resistance: Debiopharm and NetTargets will collaborate to develop next-generation, dual-payload Antibody-Drug Conjugates (ADCs) designed to overcome acquired resistance mechanisms in difficult-to-treat cancers. AI-Powered Precision: The collaboration combines NetTargets' proprietary AI discovery platform—to identify synergistic drug pairings—with Debiopharm’s MLINK Duo technology for coordinated delivery of two distinct warheads on a single ADC. Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company dedicated to developing innovative therapies that respond to high unmet medical needs, today announced a strategic research collaboration with NetTargets (www.net-targets.com), a South Korean biotech company specializing in AI-enhanced systems biology for drug discovery, to rationally design and advance the discovery of novel, synergistic drug combinations for Debiopharm’s next-generation Antibody-Drug Conjugates (ADCs). This allianc

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye